Neuronostics close oversubscribed seed funding round

SETsquared Bristol member, Neuronostics, an award-winning SME, has successfully secured £300K for the ongoing development of its revolutionary clinical decision support systems. The funds being received from a group of private investors who are establishing a new venture capital fund QantX Ventures. Neuronostics has developed patented technology that enables faster and more accurate diagnosis of…

Read More